Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Facial gender surgery techniques focus on forehead and hairline changes for accurate results.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Individuals with male pseudohermaphroditism often do better raised as females with early surgery.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

The patient had complex urinary tract issues and ambiguous genitalia, with physical features suggesting a hormonal imbalance.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

Testosterone therapy in transgender men can cause acne.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Masculinity in media is evolving to challenge traditional gender roles and promote more complex male identities.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Finasteride effectively treats hair loss in transgender men with few side effects.

Testosterone treatment may affect heart response to stress in transgender men.

The conclusion is that supportive environments are crucial for the mental health and well-being of transgender individuals during gender transition or de-transition.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Proper management of the dilation program is crucial after male-to-female reassignment surgery.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.